These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3451746)

  • 1. [Quantitative determination of feprazone in the presence of possible degradation by HPLC].
    Facchini G; Filippi G; Cantoni R; Nannetti M
    Boll Chim Farm; 1987 Jun; 126(6):244-5. PubMed ID: 3451746
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolites of feprazone in man.
    Yamaguchi H; Kubo J; Sekine K; Naruchi T; Hashimoto Y; Kato R
    Drug Metab Dispos; 1979; 7(5):340-4. PubMed ID: 40778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose study.
    Spahn H; Mutschler E
    Arzneimittelforschung; 1985; 35(1):167-9. PubMed ID: 4039147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-pressure liquid chromatographic feprazone determination in pharmaceutical formulations.
    Bonora A; Borea PA
    J Pharm Sci; 1979 Jun; 68(6):798-800. PubMed ID: 458589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas-chromatographic analysis of 4-prenyl-1,2-diphenyl-3-5-pyrazolidinedione (feprazone) at therapeutic levles in human plasma.
    Berry DJ
    J Chromatogr; 1975 Nov; 114(1):159-65. PubMed ID: 241756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feprazone in osteoarthritis: comparison of twice and 3-times daily dosage regimens.
    Laurent MR; Berry D; Grahame R
    Pharmatherapeutica; 1983; 3(6):393-7. PubMed ID: 6353430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.
    Bianchi G; Cerri B; Grasso S; Carazzi R; Dotti F; Ongari R; Cerrato O; Viara M
    Clin Ther; 1981; 3(5):349-55. PubMed ID: 7471130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(5):725-7. PubMed ID: 582968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Photolysis of prenazone in methanol and water (author's transl)].
    Reisch J; Weidmann KG; Triebe J
    Arch Pharm (Weinheim); 1977 Oct; 310(10):827-34. PubMed ID: 931568
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of feprazone in dentistry].
    Scheffer OL; de Souza S
    Dens (Curitiba); 1986; 1(1):26-32. PubMed ID: 3483175
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a feprazone-bromhexine combination in acute and chronic bronchopneumopathies].
    Alessandrini A; Bianchi RM; Geromino A; Negri L
    Clin Ter; 1983 Nov; 107(3):185-91. PubMed ID: 6362963
    [No Abstract]   [Full Text] [Related]  

  • 14. [Granulated feprazone in acute inflammatory pathology of the bronchial tree. Study in comparison to a serratiopeptidase].
    Alessandrini A; Ferrari D; Bastianon A; Maccagno A
    Clin Ter; 1985 May; 113(4):275-80. PubMed ID: 3893867
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.
    Singer F; Gruber J; Graber J; Reinthaler M; Thumb N
    Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of feprazone on phlebitis caused by the use of a temporary stimulating catheter].
    Telese M; La Tella R
    Minerva Cardioangiol; 1975 Aug; 23(8):511-7. PubMed ID: 1161162
    [No Abstract]   [Full Text] [Related]  

  • 17. HPLC method for the determination of 4-hydroxyphenylbutazone in phenylbutazone.
    Bulcsu H; Sándor G
    Acta Pharm Hung; 1980 Jul; 50(4):173-6. PubMed ID: 7270184
    [No Abstract]   [Full Text] [Related]  

  • 18. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
    Tarantino V; Stura M; Cremonesi G
    Minerva Pediatr; 1985 Oct; 37(20):827-32. PubMed ID: 3912657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy and tolerability of imidazole-2-hydroxybenzoate and feprazone in the treatment of some diseases of the respiratory tract].
    Marras F; Gini M; Ortenzi E
    Boll Chim Farm; 1985 Aug; 124(8):66S-70S. PubMed ID: 3911995
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)].
    Crone M; Geimer R
    Wien Med Wochenschr; 1981 Dec; 131(23-24):597-601. PubMed ID: 7039147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.